A six-month median can change the treatment calendar.
Introduction to Daxxify in Beverly Hills
DAXXIFY® in Beverly Hills can last a median of 24 weeks, which is about six months, and its FDA-approved cosmetic indication is the temporary improvement of moderate to severe glabellar lines in adults. [ 1 ] For patients who want a wrinkle relaxer that fits a lower-maintenance schedule, that timeline changes the conversation from routine touch-ups to a more efficient treatment rhythm.
Median durability matters. DAXXIFY's FDA-reviewed glabellar-line data showed a median duration of about 24 weeks, with patients followed through later points in the clinical program. That gives patients a meaningful reason to compare it with shorter-maintenance neuromodulators.
DAXXIFY was first FDA approved on September 8, 2022, making it one of the newest major neuromodulator options in the U.S. aesthetic market. [ 1 ] Newer does not have to mean experimental: it can mean a documented approval path, a defined cosmetic indication, and an injectable designed around a different maintenance interval.
The appeal is simple. Some people want softer frown lines without rebuilding their calendar around frequent visits. Others want a formulation story they can understand, not just a brand name they have heard before.
